In this preclinical study, we report on the effects of vaccination with adjuvanted survivin peptide-loaded microspheres on orthotopically implanted tumor growth in a 4T1 murine model of triple negative breast cancer. Here, BIRC5 is linked to triple-negative breast carcinoma.